You need to be logged in to view this video
John moderated a panel of Biotech CEOs earlier this week (October 1st) at the MicroCap Conference in NYC. The panel covered a variety of current topics of interest to investors including:
John will share with MoneyShow what biotech CEOs are thinking and what investors are asking about these topics.
John Vandermosten
Zacks Investment Research,
Senior Biotechnology Research Analyst
John Vandermosten is currently a senior biotechnology research analyst for Zacks Investment Research where he covers a portfolio of small-cap biotechnology names. His background includes 17 years of experience in a variety of investment management and research roles across all market cap ranges and throughout the capital structure. Formerly, Mr. Vandermosten was a research analyst for Singular Research covering the healthcare space and a consultant with Coker Group, a national healthcare services firm providing financial advisory, investment banking, healthcare IT, and other services to hospitals and other health care organizations.
Trending Now
Filter By Category
Filter By Keywords
Loading...